EA
Emerald Advisers Portfolio holdings
AUM
$2.73B
This Quarter Return
+6.36%
1 Year Return
+54.29%
3 Year Return
+280.05%
5 Year Return
+497.66%
10 Year Return
+2,067.91%
AUM
$1.94B
AUM Growth
+$1.94B
(-0.32%)
Cap. Flow
+$12.4M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
18.4%
Holding
264
New
14
Increased
88
Reduced
101
Closed
15
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$21M |
| 2 |
Celsius Holdings
CELH
|
$19.3M |
| 3 |
Northern Oil and Gas
NOG
|
$18.4M |
| 4 |
AdaptHealth
AHCO
|
$17.7M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$17.3M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$24.9M |
| 2 |
Onto Innovation
ONTO
|
$20M |
| 3 |
Alkermes
ALKS
|
$16.5M |
| 4 |
Avient
AVNT
|
$15.9M |
| 5 |
Chart Industries
GTLS
|
$15.6M |
Sector Composition
| 1 | Healthcare | 30.67% |
| 2 | Industrials | 16.05% |
| 3 | Consumer Discretionary | 13.81% |
| 4 | Technology | 13.49% |
| 5 | Financials | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Exponent
EXPO
$3.63B
| $23.4M | 1.21% |
267,270
+117,878
| +79% | +$10.3M |
|
27
Moelis & Co
MC
$5.21B
| $22.6M | 1.17% |
668,614
-108,491
| -14% | -$3.67M |
|
|
CUTR
28
DELISTED
Cutera, Inc.
CUTR
| $21.8M | 1.12% |
477,833
+17,601
| +4% | +$803K |
|
29
Acadia Pharmaceuticals
ACAD
$4.34B
| $21.8M | 1.12% |
1,329,626
+468,877
| +54% | +$7.67M |
|
30
Jack in the Box
JACK
$339M
| $21.3M | 1.1% |
287,087
| – | – |
|
|
BPMC
31
DELISTED
Blueprint Medicines
BPMC
| $21M | 1.08% |
+318,574
| New | +$21M |
|
32
Rapid7
RPD
$1.32B
| $20.9M | 1.08% |
486,797
-35,694
| -7% | -$1.53M |
|
33
Transmedics
TMDX
$3.65B
| $20.7M | 1.07% |
494,926
+97,361
| +24% | +$4.06M |
|
34
Replimune Group
REPL
$460M
| $19.6M | 1.01% |
1,136,586
+43,263
| +4% | +$747K |
|
35
United Therapeutics
UTHR
$17.7B
| $19.5M | 1.01% |
93,253
-66,840
| -42% | -$14M |
|
36
Kratos Defense & Security Solutions
KTOS
$10.9B
| $19.5M | 1.01% |
1,919,534
+247,198
| +15% | +$2.51M |
|
37
Carpenter Technology
CRS
$11.8B
| $19.5M | 1.01% |
625,868
+162
| +0% | +$5.05K |
|
|
38
Celsius Holdings
CELH
$15.8B
| $19.3M | 0.99% |
+637,431
| New | +$19.3M |
|
39
Forward Air
FWRD
$923M
| $19M | 0.98% |
210,798
+60
| +0% | +$5.42K |
|
|
40
Northern Oil and Gas
NOG
$2.5B
| $18.9M | 0.98% |
691,302
+671,052
| +3,314% | +$18.4M |
|
41
Matador Resources
MTDR
$6.09B
| $18.6M | 0.96% |
380,877
+32,197
| +9% | +$1.58M |
|
42
Integer Holdings
ITGR
$3.71B
| $18.6M | 0.96% |
298,641
-39
| -0% | -$2.43K |
|
43
NeoGenomics
NEO
$1.06B
| $18.4M | 0.95% |
2,139,579
+926,226
| +76% | +$7.97M |
|
44
DocGo
DCGO
$152M
| $18.4M | 0.95% |
1,854,392
+11,153
| +0.6% | +$111K |
|
|
45
AdaptHealth
AHCO
$1.23B
| $18.1M | 0.93% |
964,246
+941,018
| +4,051% | +$17.7M |
|
46
ProFrac Holding
ACDC
$682M
| $18M | 0.93% |
1,181,931
+306,933
| +35% | +$4.67M |
|
|
ISEE
47
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $17.3M | 0.89% |
+962,907
| New | +$17.3M |
|
48
Amylyx Pharmaceuticals
AMLX
$877M
| $16.9M | 0.87% |
+601,226
| New | +$16.9M |
|
49
AtriCure
ATRC
$1.73B
| $16.8M | 0.86% |
428,631
+200
| +0% | +$7.82K |
|
50
Cytokinetics
CYTK
$5.98B
| $16.5M | 0.85% |
340,610
+196,300
| +136% | +$9.51M |
|